Corporate AI Training in the AI Bubble Era: Teamland Urges Leaders to Invest in People Over Hype

Teamland today warned that the AI “gold rush” is stalling inside organizations, not because of tools, but because of people's readiness. In a new position statement, the company calls time on “training theater” and urges leaders to invest in practical upskilling that turns AI's promise into day-to-day practice. https://mma.prnewswire.com/media/2798642/Teamland_Teamland_Calls_Time_on_AI_Bubble__Invest_in_People_to_T.jpg “Executives don't have a tool problem, […]

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

(TSX-V:XRTX),(NASDAQ:XRTX),(Boerse Frankfurt – Freiverkehr:ANUA.F), CALGARY, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has entered into a securities purchase agreement

Are Bitcoin and XRP facing a crisis of confidence? With $15 billion locked up in the US, are cryptocurrencies safe?

Key Highlights 1.NB HASH introduces its new AI Compute + RWA Asset dual-engine model, creating a transparent, on-chain real-yield framework.2.All new users receive a $20 Free Experience Plan upon registration — no KYC required — plus daily check-in rewards.3.Now serving over 10 million users across 180 countries, NB HASH is driving global participation in AI-based

GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio

LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — GLD Partners, LP, with a growing footprint of investments in life sciences, healthcare, and biotech, today announced the successful acquisition of select assets from Seelos Therapeutics, Inc. through the Chapter 11 bankruptcy process. Following its acquisition of Seelos' senior secured debt, GLD served as the stalking horse

Genius Group Title Sponsor of Coindesk’s Bitcoin Treasury Month, Awarding 100 Million Satoshis in Prize Money

(NYSE MKT:GNS), SINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it is the Title Sponsor of Coindesk's Bitcoin Treasury Theme Month, with 100 million Satoshis (equal to one Bitcoin) in prize money. CoinDesk, a leading site

Ferroglobe PLC Schedules Third Quarter 2025 Earnings Call for November 6, 2025

(NASDAQ:GSM), LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025, and will host the quarterly earnings call on Thursday, November 6, 2025, at 8:30 a.m. Eastern Time. To join via phone: Conference call

CEA Industries ($BNC) Crosses Half-Million BNB Milestone

(NASDAQ:BNC),(NASDAQ:BNCWW), Louisville, CO, Oct. 21, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”) today announced that it now holds a total of 500,000 BNB tokens, with an average acquisition cost of approximately $870 per BNB, representing a total invested amount of $435 million and an estimated BNB value of $546.8million

PetVivo Holdings, Inc. Addresses Veterinary Industry’s GEN Z Problem With Breakthrough AI License Agreement

(Other OTC:PETV),(OTC US:PETV),(OTC US:PETVW),(Other OTC:PETVW), MINNEAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., an emerging biomedical device company focused on the commercialization of groundbreaking medical products for horses and companion animals, today announced it has entered into an exclusive

Atossa Therapeutics Highlights Progress in RECAST™ DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents

Investor-focused update underscores enrollment momentum, biomarker strategy, and near-term data readouts designed to de-risk development of (Z)-Endoxifen and other endocrine therapies for DCIS Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD, MBA, Professor of Surgery and Radiology at

SharpLink Reports Total ETH Holdings Rise to 859,853 as of October 19, 2025; Total ETH and Cash Holdings of $3.5 Billion

(NASDAQ:SBET), Minneapolis, MN, Oct. 21, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced that as of October 19, 2025, SharpLink's total ETH holdings increased to 859,8531, reflecting the Company's continued commitment

Scroll to Top